Novartis, Otsuka, Pfizer, Sanofi join Verily's Project Baseline

"Novartis, Otsuka, Pfizer and Sanofi have signed onto Verily’s Project Baseline, a program aimed at mapping out a baseline for human health. In the coming years, the pharma partners will carry out clinical studies using technology developed under Project Baseline, in disease areas such as cancer, mental health, diabetes, dermatology and heart disease. Verily kicked off Project Baseline in April 2017, with a health study geared to gather health data..." Lire la suite